PofoliaShared via Pofolia

Frontiers in Psychiatry· 2024Q1

Cannabidiol usage, efficacy, and side effects: analyzing the impact of health conditions, medications, and cannabis use in a cross-sectional online pilot study

Alicja Anna Binkowska, Natalia Jakubowska, Anna Redeł, Sandra Laskowska et al.

Short summary

Nearly 70% of CBD users in a pilot study (n=267) reported finding CBD effective for stress, sleep, well-being, mood, and anxiety, with those having psychiatric disorders or on psychotropic medications more likely to use it for stress/anxiety relief.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Nearly 70% of 267 CBD users reported CBD products to be effective.
  • Top reasons for CBD use included self-reported stress (65.3%), sleep problems (51.7%), and overall well-being (52.5%).
  • Individuals with psychiatric disorders and those on psychotropic medications were more likely to use CBD for stress and anxiety relief.
  • Administration preferences differed: sublingual for non-cannabis users, smoking/vaping for cannabis users.

AI-generated from the title and abstract; the full text is not read.

Abstract

Background: Products containing cannabidiol (CBD) are attracting attention because of their potential therapeutic benefits and positive impacts on well-being and mental health. Although additional research is needed to understand their effectiveness in treating mental disorders, cross-sectional studies may help identify the factors influencing CBD use patterns. This study examined the impact of variables such as health status, medication use, medical supervision, gender, age, and cannabis use on CBD consumption patterns. Materials and methods: A self-selected sample (n =267) of current or former CBD users was recruited via social media and participated in an online survey designed to collect data on basic demographics, health status, cannabis use, and CBD usage patterns. Results: The sample (n = 267) consisted of 68.5% women with an average age of 30.21 years, of which 25.8% reported diagnosed psychiatric disorders and 49.4% reported cannabis use. The top five reasons for using CBD were self-reported stress (65.3%), sleep problems (51.7%), overall improvement in well-being (52.5%), improved mood (44.9%), and anxiety relief (40.9%). Our findings suggest that individuals with psychiatric disorders and those taking psychotropic medications are more likely to use CBD to relieve stress and anxiety. Overall, nearly 70% of the individuals found CBD products to be effective. Sublingual administration was more popular among non-cannabis users, while cannabis users preferred smoking and vaping to CBD administration. Conclusion: Our results indicate that individuals using CBD for health and wellness reasons believe that it has potential health benefits. Further research using rigorous longitudinal designs is needed to delve deeper into the effectiveness of low-dose CBD and to better understand the therapeutic potential of CBD.

The authors' abstract, as published at the source. Frontiers in Psychiatry, 2024 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Pharmacology (Medicine)

PharmacologyMedicine